The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62089-3 · Cited by 1,663
Yusuf, S., Islam, S., Chow, C. K., Rangarajan, S., Dagenais, G., Diaz, R., Gupta, R., Kelishadi, R., Iqbal, R., Avezum, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61215-4 · Cited by 964
Sanne, I., Orrell, C., Fox, M. P., Conradie, F., Ive, P., Zeinecker, J., Cornell, M., Heiberg, C., Ingram, C., Panchia, R., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60894-x · Cited by 248
The right to health in the courts of Brazil: worsening health inequities?
Ferraz, O. L. M. (2009) · University of Warwick · doi:10.82444/warw.33605683 · Cited by 204
Lonn, E., Bosch, J., Teo, K. K., Pais, P., Xavier, D., & Yusuf, S. (2010) · Circulation · doi:10.1161/circulationaha.109.873232 · Cited by 174
Barrington, J., Wereko-Brobby, O., Ward, P., Mwafongo, W., & Kungulwe, S. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-298 · Cited by 163
Research works printed but not linked: 39
- Di Cesare, 2013, Inequalities in non-communicable diseases and effective responses, Lancet, 10.1016/S0140-6736(12)61851-0 · DOI · Paper page
- Cameron, 2009, Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis, Lancet, 373, 240, 10.1016/S0140-6736(08)61762-6 · DOI · Paper page
- O'Brien M, Mwangi-Powell F, Adewole I, et al. Improving access to analgesic drugs for patients with cancer in sub-Saharan Africa. Lancet Oncology (in press).
- Alleyne, 2013, Embedding of non-communicable diseases in the post-2015 development agenda, Lancet, 10.1016/S0140-6736(12)61806-6 · DOI · Paper page
- Hogerzeil, 2006, Human rights and essential medicines: what can they learn from each other?, Bull World Health Organ, 84, 371, 10.2471/BLT.06.031153 · DOI
- Perehudoff, 2010, Access to essential medicines in national constitutions, Bull World Health Organ, 88, 800, 10.2471/BLT.10.078733 · doi:10.2471/blt.10.078733
- Hogerzeil, 2006, Is access to essential medicines as part of the fulfillment of the right to health enforceable through the courts?, Lancet, 368, 305, 10.1016/S0140-6736(06)69076-4 · doi:10.1016/s0140-6736(06)69076-4
- Lim, 2007, Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs, Lancet, 370, 2054, 10.1016/S0140-6736(07)61699-7 · DOI · Paper page
- Atun, 2013, Improving responsiveness of health systems to non-communicable diseases, Lancet, 10.1016/S0140-6736(13)60063-X · DOI · Paper page
- Bigdeli, 2012, Access to medicines from a health system perspective, Health Policy Plan
- Kanavos, 2008, Generic policies: rhetoric versus reality, Euro Observer, 10, 1
- Twagirumukiza, 2010, Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines, Trop Med Int Health, 15, 350, 10.1111/j.1365-3156.2009.02453.x · DOI
- Caudron, 2008, Substandard medicines in resource-poor settings: a problem that can no longer be ignored, Trop Med Int Health, 13, 1062, 10.1111/j.1365-3156.2008.02106.x · DOI · Paper page
- Twagirumukiza, 2009, Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies, Am J Trop Med Hyg, 81, 776, 10.4269/ajtmh.2009.09-0109 · DOI
- Laing, 2001, Ten recommendations to promote improved use of medicines in developing countries, Health Policy Plan, 16, 13, 10.1093/heapol/16.1.13 · DOI · Paper page
- Wagner, 2011, Access to care and medicines, burden of health care expenditures and risk protection: results from the World Health Survey, Health Policy, 100, 151, 10.1016/j.healthpol.2010.08.004 · DOI
- Frenk, 2012, Universal health coverage: good health, good economics, Lancet, 308, 862, 10.1016/S0140-6736(12)61341-5 · DOI
- Reddy, 2011, Towards achievement of universal health care in India by 2020: a call to action, Lancet, 377, 760, 10.1016/S0140-6736(10)61960-5 · DOI · Paper page
- Hardon, 2007, Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa, AIDS Care, 19, 658, 10.1080/09540120701244943 · DOI · Paper page
- Marquez, 2012, No more disease silos for sub-Saharan Africa, BMJ, 345, e5812, 10.1136/bmj.e5812 · DOI
- Gilks, 2006, The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings, Lancet, 368, 505, 10.1016/S0140-6736(06)69158-7 · DOI · Paper page
- Ford, 2011, The first decade of antiretroviral therapy in Africa, Global Health, 7, 33, 10.1186/1744-8603-7-33 · DOI
- Mills, 2012, Adherence to antiretroviral therapy: supervision or support?, Lancet Infect Dis, 12, 97, 10.1016/S1473-3099(11)70354-1 · DOI
- Ford, 2009, Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials, Lancet, 374, 2064, 10.1016/S0140-6736(09)61671-8 · DOI
- Wald, 2003, A strategy to reduce cardiovascular disease by more than 80%, BMJ, 326, 1419, 10.1136/bmj.326.7404.1419 · DOI · Paper page
- Panchagnula, 2004, Fixed dose combinations for tuberculosis: lessons learned from clinical, formulation and regulatory perspective, Methods Find Exp Clin Pharmacol, 26, 703, 10.1358/mf.2004.26.9.872568 · DOI
- Kishore, 2011, Promoting global cardiovascular health: ensuring access to cardiovascular medicines in low- and middle-income countries, J Am Coll Cardiol, 57, 1980, 10.1016/j.jacc.2010.12.029 · doi:10.1016/j.jacc.2010.12.029
- Moon, 2011, A win-win solution? A critical analysis of tiered pricing to improve access to medicines in developing countries, Global Health, 7, 39, 10.1186/1744-8603-7-39 · DOI
- Downing, 2012, Avoidance of generic competition by Abbott Laboratories' fenofibrate franchise, Arch Intern Med, 172, 724, 10.1001/archinternmed.2012.187 · DOI
- Liberman, 2011, Implications of international law for the treatment of cancer: the Single Convention on Narcotic Drugs and the TRIPS Agreement, Public Health, 125, 840, 10.1016/j.puhe.2011.09.032 · doi:10.1016/j.puhe.2011.09.032
- Outterson, 2008, Should access to medicines and TRIPS flexibilities be limited to specific diseases?, Am J Law Med, 34, 317, 10.1177/009885880803400208 · DOI
- Roderick, 2012, India's patent laws under pressure, Lancet, 380, e2, 10.1016/S0140-6736(12)61513-X · doi:10.1016/s0140-6736(12)61513-x
- Waning, 2010, A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries, J Int AIDS Soc, 13, 35, 10.1186/1758-2652-13-35 · DOI
- Smith, 2009, Trade, TRIPS, and pharmaceuticals, Lancet, 373, 684, 10.1016/S0140-6736(08)61779-1 · DOI · Paper page
- Maxmen, 2012, Trade deal to curb generic drug use, Nature, 489, 16, 10.1038/489016a · doi:10.1038/489016a
- Heath, 2011, Seeming virtuous on chronic diseases, BMJ, 343, d4239, 10.1136/bmj.d4239 · doi:10.1136/bmj.d4239
- Gale, 2012, Post-marketing studies of new insulins: sales or science?, BMJ, 344, e3974, 10.1136/bmj.e3974 · DOI
- Goroff, 2010, Partnerships to provide care and medicine for chronic diseases: a model for emerging markets, Health Aff, 29, 2206, 10.1377/hlthaff.2009.0896 · DOI
- Colombo, 2012, Patient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian survey, PLoS One, 7, e34974, 10.1371/journal.pone.0034974 · DOI
Cited by
The global epidemiology of hypertension
Mills, K. T., Stefanescu, A., & He, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0244-2 · Cited by 4,133
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531
Bennett, J. E., Stevens, G. A., Mathers, C. D., Bonita, R., Rehm, J., Kruk, M. E., Riley, L. M., Dain, K., Kengne, A. P., Chalkidou, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31992-5 · Cited by 1,336
Self-citationBekker, L.-G., Alleyne, G., Baral, S., Cepeda, J., Daskalakis, D., Dowdy, D., Dybul, M., Eholie, S., Esom, K., Garnett, G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31070-5 · Cited by 763
Inequalities in non-communicable diseases and effective responses
Di Cesare, M., Khang, Y.-H., Asaria, P., Blakely, T., Cowan, M. J., Farzadfar, F., Guerrero, R., Ikeda, N., Kyobutungi, C., Msyamboza, K. P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61851-0 · Cited by 678
Metadata
- Authors
- Hogerzeil, H. V., Liberman, J., Wirtz, V. J., Kishore, S. P., Selvaraj, S., Kiddell-Monroe, R., Mwangi-Powell, F. N., & von Schoen-Angerer, T.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 381
- Issue
- 9867
- Pages
- 680-689
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138490742
- Cited by
- 202
- References
- 6
- FWCI
- 51.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. https://app.cochat.ai/papers/10.1016/s0140-6736(12)62128-x
- The paper
- Hogerzeil, H. V., Liberman, J., Wirtz, V. J., Kishore, S. P., Selvaraj, S., Kiddell-Monroe, R., Mwangi-Powell, F. N., & von Schoen-Angerer, T. (2013). Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. The Lancet. https://doi.org/10.1016/s0140-6736(12)62128-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.